Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Operating Expenses: 2009-2024

Historic Operating Expenses for Cytokinetics (CYTK) over the last 16 years, with Dec 2024 value amounting to $554.7 million.

  • Cytokinetics' Operating Expenses rose 19.42% to $168.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $660.1 million, marking a year-over-year increase of 25.06%. This contributed to the annual value of $554.7 million for FY2024, which is 10.12% up from last year.
  • Per Cytokinetics' latest filing, its Operating Expenses stood at $554.7 million for FY2024, which was up 10.12% from $503.7 million recorded in FY2023.
  • In the past 5 years, Cytokinetics' Operating Expenses ranged from a high of $554.7 million in FY2024 and a low of $149.8 million during FY2020.
  • In the last 3 years, Cytokinetics' Operating Expenses had a median value of $503.7 million in 2023 and averaged $492.4 million.
  • Data for Cytokinetics' Operating Expenses shows a peak YoY soared of 71.42% (in 2021) over the last 5 years.
  • Over the past 5 years, Cytokinetics' Operating Expenses (Yearly) stood at $149.8 million in 2020, then skyrocketed by 71.42% to $256.7 million in 2021, then spiked by 63.12% to $418.8 million in 2022, then climbed by 20.28% to $503.7 million in 2023, then grew by 10.12% to $554.7 million in 2024.